National Council for Prescription Drug Programs indexing - billing unit
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Label type
- Indexing - Billing Unit
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 03:04:55
Label at a glance#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0046-1105-11 | EA - Each | 0046-1105 | f6028d33-05ff-45a2-9ff4-feac4b6b2e77 | 1 | 2012-07-24 |
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0046-1105 | 0046-1105-11 |
Source Document#
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020527-001 | PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | |
| N020527-002 | PREMPHASE 14/14 | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | |
| N020527-003 | PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | |
| N020527-004 | PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | |
| N020527-005 | PREMPRO | ESTROGENS, CONJUGATED; MEDROXYPROGESTERONE ACETATE | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020527-001 | PREMPRO | 0.625MG;2.5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020527-002 | PREMPHASE 14/14 | 0.625MG,0.625MG;N/A,5MG | TABLET / ORAL-28 | RLD, RS | 1995-11-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020527-003 | PREMPRO | 0.625MG;5MG | TABLET / ORAL-28 | RLD, RS | 1998-01-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020527-004 | PREMPRO | 0.45MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-03-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020527-005 | PREMPRO | 0.3MG;1.5MG | TABLET / ORAL-28 | RLD, RS | 2003-06-04 | 03ed91905a0d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prempro | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | fd0c0836-5d23-2183-da81-9dc7f4287052 | 2026-04-28 | Boxed warning, Warnings, Adverse reactions | 0046-1105-11 00046110511 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.